Page last updated: 2024-08-21

alpha-naphthoflavone and bortezomib

alpha-naphthoflavone has been researched along with bortezomib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Bruyne, E; Hu, J; Menu, E; Schots, R; Van Valckenborgh, E; Vanderkerken, K; Xu, D	1

Other Studies

1 other study(ies) available for alpha-naphthoflavone and bortezomib

Article	Year
Dll1/Notch activation contributes to bortezomib resistance by upregulating CYP1A1 in multiple myeloma. Biochemical and biophysical research communications, 2012, Nov-30, Volume: 428, Issue:4 Topics: Animals; Antineoplastic Agents; Benzoflavones; Boronic Acids; Bortezomib; Calcium-Binding Proteins; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Drug Resistance, Neoplasm; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Multiple Myeloma; Pyrazines; Receptors, Notch; Up-Regulation	2012

Article

Year

Dll1/Notch activation contributes to bortezomib resistance by upregulating CYP1A1 in multiple myeloma.

Biochemical and biophysical research communications, 2012, Nov-30, Volume: 428, Issue:4

Topics: Animals; Antineoplastic Agents; Benzoflavones; Boronic Acids; Bortezomib; Calcium-Binding Proteins; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Drug Resistance, Neoplasm; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Multiple Myeloma; Pyrazines; Receptors, Notch; Up-Regulation

2012